PharmaCann Polska steps closer to selling Macedonian medical cannabis in Poland, Germany

PharmaCann Polska steps closer to selling Macedonian medical cannabis in Poland, Germany
By bne IntelliNews September 10, 2020

Warsaw-based PharmaCann Polska is one step closer to being able to offer its medical cannabis extracts, produced at its North Macedonia plant, in Germany and Poland.

This is possible after the company became the first company to obtain EU-Good Manufacturing Practice (GMP) certification to produce medical cannabis extracts at its facility in North Macedonia.

Medical cannabis products were legalised in Macedonia by the former VMRO-DPMNE government in 2016. Unlike in most EU countries, production has not been carried out by a state monopoly, which has resulted in a high level of interest in North Macedonia as a potential production base for numerous companies, both local and international.

After being placed on the market, Macedonian products, just like Columbian ones, are expected to create price pressure due to lower production costs, specialised news provider Marijuana Business Daily reported on September 10.

The GMP certificates were issued in March by Poland's Chief Pharmaceutical Inspectorate, after Polish authorities inspected PharmaCann’s Macedonian subsidiary, known as NYSK, in December 2019.

PharmaCann Polska's CEO Zlatko Keskovski told Marijuana Business Daily that the company expects to start selling directly to pharmacies using its own distribution asset in Germany by the end of September while sales in Poland are expected by November.

In Poland only a few flower varieties have been registered by Canadian producers Aurora Cannabis and Canopy Growth.

The Macedonian company has already shipped small quantities of product to Australia, Brazil, Croatia, Slovenia, South Africa and the UK, according to Keskovski.

Macedonian cannabis producers cannot export flower, but the situation is expected to change soon. For this purpose, PharmaCann is finalising a project involving a bigger facility in another location in North Macedonia.

Dozens of cannabis production licenses have been issued in North Macedonia, but many of them are not fully operational.

Related Articles

EIB surpasses investment milestone in the Western Balkans by investing €1.2bn in 2023

EIB Global, the financial arm of the European Investment Bank (EIB) for activities beyond the EU, set a new record by investing €1.2bn in the Western Balkans in 2023, the EIB said on February 9. ... ... more

bne IntelliNews Southeast Europe Outlook 2024

This Southeast Europe Outlook 2024 has been prepared by bne IntelliNews as part of a series of annual reviews providing updates on the geopolitical, macroeconomic and commercial state of ... more

North Macedonia banks' loan portfolio expands 5.3% y/y, deposits up 8% y/y at end-October

The total loan portfolio of North Macedonia’s commercial banks expanded by an annual 5.3% at the end of October to MKD437.7bn (€7.1bn), slowing slightly from a 5.8% y/y increase in the previous ... more

Dismiss